Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Domain Associates
AddedMar 19, 2024
UpdatedJul 16, 2026
Domain Associates

Domain Associates

Operating

Innovative dental pharmaceuticals reversing anesthetic effects.

Location
San Diego, CA, US
Founded
1985
Firm
Compare
Portfolio
Fundraising
Employees
Website

Domain Associates, founded in 1985, is a venture capital firm that exclusively invests in life science companies advancing human health. The firm typically participates in Series A, B, and C funding rounds, with a strong focus on biopharmaceuticals, medical devices, and diagnostic companies. Domain Associates has managed multiple biotech VC funds and has a significant presence in the life sciences sector.

Notable portfolio companies include Antios Therapeutics, Align Technology, and Veracyte. Key partners at Domain Associates include James Blair, Brian Halak, and Kim Kamdar. The firm is known for its deep industry expertise and extensive network, offering strategic guidance and operational support to its portfolio companies. This value-add approach helps startups navigate the complexities of the healthcare market and achieve successful exits through IPOs and M&A events.

Domain Associates - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments148
Current Portfolio Count52
Total Portfolio Exits10

Top Investment Stages

Series B41 (30.8%)
Series A35 (26.3%)
Series C23 (17.3%)
Series Unknown19 (14.3%)
Series D15 (11.3%)

Stage Mix

Series B 31%Series A 26%Series C 17%Series Unknown 14%Series D 11%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Epic Sciences logo

Epic Sciences

Antios Therapeutics logo

Antios Therapeutics

Axial Therapeutics logo

Axial Therapeutics

Nobias Therapeutics logo

Nobias Therapeutics

Exalys Therapeutics logo

Exalys Therapeutics

Seraphina Therapeutics logo

Seraphina Therapeutics

Aspen Neuroscience logo

Aspen Neuroscience

Singular Genomics logo

Singular Genomics

ChromaCode logo

ChromaCode

Truvian logo

Truvian

Windmil Therapeutics logo

Windmil Therapeutics

Celtaxsys logo

Celtaxsys

Sebacia logo

Sebacia

Adynxx logo

Adynxx

ReVision Optics logo

ReVision Optics

Gene Sciences logo

Gene Sciences

Rox Medical logo

Rox Medical

Bionano Genomics logo

Bionano Genomics

Benvenue Medical logo

Benvenue Medical

Syndax Pharmaceuticals logo

Syndax Pharmaceuticals

aTyr Pharma logo

aTyr Pharma

Sera Prognostics logo

Sera Prognostics

VentiRx Pharmaceuticals logo

VentiRx Pharmaceuticals

Atara Biotherapeutics logo

Atara Biotherapeutics

RightCare Solutions logo

RightCare Solutions

Domain Associates - Similar Investment Firms

Draper Associates logo

Draper Associates

draper.vc

Dom Capital Group logo

Dom Capital Group

Dominion Capital logo

Dominion Capital

domcapllc.com

Durand Venture Associates logo

Durand Venture Associates

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

Digitalis Ventures logo

Digitalis Ventures

Kleiner Perkins Caufield & Byers logo

Kleiner Perkins Caufield & Byers

kleinerperkins.com

Technology Associates Management logo

Technology Associates Management

Dcvc logo

Dcvc

dcvc.com

Bionovus Innovations logo

Bionovus Innovations

Dcvc Bio logo

Dcvc Bio

dcvc.com

Vertex Ventures HC logo

Vertex Ventures HC

Atlas Venture logo

Atlas Venture

atlasventure.com

Distributed Ventures logo

Distributed Ventures

distributedvc.com

Denali Ventures logo

Denali Ventures

Domain Associates - Classification

Also Known As
  • Domain Associates L.L.C.
NAICS
  • 520000Finance and Insurance
  • 620000Health Care and Social Assistance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 623000Nursing and Residential Care Facilities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 8000Health Services
  • 6790Miscellaneous Investing
  • 8040Offices And Clinics Of Other Health Practitioners
  • 6799Investors, Not Elsewhere Classified
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
  • 6820Real estate activities on a fee or contract basis
  • 6910Legal activities
Show 34 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 530000Real Estate and Rental and Leasing
  • 531000Real Estate
  • 531300Activities Related to Real Estate
  • 531390Other Activities Related to Real Estate
  • 540000Professional, Scientific, and Technical Services
  • 541110Offices of Lawyers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 541000Professional, Scientific, and Technical Services
  • 541100Legal Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 6500Real Estate
  • 6530Real Estate Agents And Managers
  • 6531Real Estate Agents And Managers
  • 8100Legal Services
  • 8110Legal Services
  • 8111Legal Services
  • 2800Chemicals And Allied Products
  • 6000Depository Institutions
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 6720Investment Offices
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 6722Management Investment Offices, Open-end
  • 8731Commercial Physical and Biological Research